$3.86
0.256.93%
Last update: Nov 6, 3:22 PM
Aclaris Therapeutics Inc
ACRSNASDAQ
The average analyst price target for Aclaris Therapeutics is $9.85, 155.2% above the current price. Of 13 analysts, 11 rate it Buy and 2 Hold. Targets range from $1 to $16. The latest change came on Oct 30, 2026, when Canaccord Genuity raised its price target on Aclaris Therapeutics from $10 to $13 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
